Process for the early detection of recurrence after therapy for prostate cancer

摘要

A method for detecting whether a patient has a biochemical recurrence in early stage (ES - BCR) otiene stable disease, comprising a) providing two or more samples obtained from the patient at 18 months after therapy parael prostate cancer ; b) measuring the PSA level in the sample using an immunoassay format for the PSA sándwichheterogéneo with a detection limit at least as low as 2.0 pg / ml, using dichoinmunoensayo in a sandwich format reaction polymerase chain (PCR) for generating laseñal; c) using the PSA level samples to determine a PSA value; where ES - BCR is detected if the PSA value is at least or exceeds a PSA indicator and the enfermedadestable is detected if the PSA value does not exceed the PSA indicator, wherein the PSA indicator is a rate of increase in [PSA] of about 2.0 pg / mL / month.